Table 2.
Characteristics of the included articles.
| First author | Publication year | Study design | Number of patients | Clinical setting | Imaging technique | Journal (Radiological or not radiological) | Features (First order/more) | ML (Yes/No) |
|---|---|---|---|---|---|---|---|---|
| Gong[40] | 2022 | Retrospective | 224 | NSCLCa | CT | Not Radiological | More | Yes |
| Rundo[41] | 2019 | Retrospective | 43 | Bladder Cancer | CT | Not Radiological | More | Yes |
| Ho[42] | 2023 | Retrospective | 26 | HCCa | MRI | Not Radiological | More | No |
| Khorrami[43] | 2020 | Retrospective | 139 | NSCLC | CT | Not Radiological | More | No |
| Xie[44] | 2022 | Retrospective | 97 | NSCLC | CT | Not Radiological | More | No |
| Qu[45] | 2023 | Retrospective | 76 | Colorectal liver metastases | CT | Not Radiological | More | Yes |
| Liu[46] | 2021 | Retrospective | 197 | NSCLC | CT | Not Radiological | More | No |
| Guerrisi[47] | 2021 | Retrospective | 78 | Metastatic Melanoma | CT | Not Radiological | More | No |
| Barabino[19] | 2022 | Retrospective | 33 | NSCLC | CT | Not Radiological | More | No |
| Chen[48] | 2021 | Retrospective | 50 | Metastatic Melanoma | CT | Not Radiological | More | Yes |
| Li[49] | 2023 | Retrospective | 101 | Gastric Cancer | CT | Not Radiological | More | No |
| Wang[50] | 2020 | Retrospective | 50 | Metastatic Melanoma | CT | Not Radiological | More | Yes |
| Tankyevych[51] | 2022 | Retrospective | 83 | NSCLC | FDG-PET/CT | Not Radiological | More | Yes |
a
NSCLC Non-small-cell lung cancer, HCC Hepatocellular carcinoma.